Arno A. van de Bovenkamp

Arno A. van de Bovenkamp

Auto-generated profile, based on publicly available information

Arno A. van de Bovenkamp

Vrije Universiteit Amsterdam

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2022 in Circulation: Heart Failure
Verified
Journal Article
Open access
PDF file
ABArno A. van de Bovenkamp
Arno A. van de Bovenkamp
NWNiels Wijkstra
Niels Wijkstra
FOFrank P.T. Oosterveer
Frank P.T. Oosterveer
ANAnton Vonk Noordegraaf
Anton Vonk Noordegraaf
HBHarm-Jan Bogaard
Harm-Jan Bogaard
MHM. Louis Handoko
M. Louis Handoko
Background: Because of limited accuracy of noninvasive tests, diastolic stress testing plays an important role in the diagnostic work-up of patients with heart failure with preserved ejection fraction (HFpEF). Exercise right heart catheterization is considered the gold standard and indicated when HFpEF is suspected but left ventricular filling pressures at rest are normal. However, performing exercise during right heart catheterization is not universally available. Here, we examined whether pulmonary capillary wedge pressure (PCWP) during a passive leg raise (PLR) could be used as simple and accurate method to diagnose or rule out occult-HFpEF. Methods: In our tertiary center for pulmonary hypertension and HFpEF, all patients who received a diagnostic right heart catheterization with PCWP-measurements at rest, PLR, and exercise were evaluated (2014–2020). The diagnostic value of PCWP PLR was compared with the gold standard (PCWP EXERCISE ). Cut-offs derived from our cohort were subsequently validated in an external cohort (N=74). Results: Thirty-nine non-HFpEF, 33 occult-HFpEF, and 37 manifest-HFpEF patients were included (N=109). In patients with normal PCWP REST (<15 mmHg), PCWP PLR significantly improved diagnostic accuracy compared with PCWP REST (AUC=0.82 versus 0.69, P =0.03). PCWP PLR ≥19 mmHg (24% of cases) had a specificity of 100% for diagnosing occult-HFpEF, irrespective of diuretic use. PCWP PLR ≥11 mmHg had a 100% sensitivity and negative predictive value for diagnosing occult-HFpEF. Both cut-offs retained a 100% specificity and 100% sensitivity in the external cohort. Absolute change in PCWP PLR or V-wave derived parameters had no incremental value in diagnosing occult-HFpEF. Conclusions: PCWP PLR is a simple and powerful tool that can help to diagnose or rule out occult-HFpEF.

21 September 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
ABArno A. van de Bovenkamp
Arno A. van de Bovenkamp
VEVidya Enait
Vidya Enait
FMFrances S. De Man
Frances S. De Man
FOFrank T. P. Oosterveer
Frank T. P. Oosterveer
HBHarm-Jan Bogaard
Harm-Jan Bogaard
MHM. Louis Handoko
M. Louis Handoko
Background: Echocardiography is considered the cornerstone of the diagnostic workup of heart failure with preserved ejection fraction. Thus far, validation of the 2016 American Society of Echocardiography/European Association of Cardiovascular Imaging (ASE/EACVI) echo‐algorithm for evaluation of diastolic (dys)function in a patient suspected of heart failure with preserved ejection fraction has been limited. Methods and Results: The diagnostic performance of the 2016 ASE/EACVI algorithm was assessed in 204 patients evaluated for unexplained dyspnea or pulmonary hypertension with echocardiogram and right heart catheterization. Invasively measured pulmonary capillary wedge pressure (PCWP) was used as the gold standard. In addition, the diagnostic performance of H 2 FPEF score and NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) were evaluated. There was a poor correlation between indexed left atrial volume, E/e′ (septal and average) or early mitral inflow (E), and PCWP ( r =0.25–0.30, P values all <0.01). No correlation was found in our cohort between e′ (septal or lateral) or tricuspid valve regurgitation and PCWP. The correlation between diastolic function grades of the ASE/EACVI algorithm and PCWP was poor ( r =0.17, P <0.05). The ASE/EACVI algorithm had a sensitivity and specificity of 35% and 87%, respectively; an accuracy of 67% and an area under the curve of 0.56. Moreover, in 30% of cases the algorithm was not applicable or indeterminate. H 2 FPEF score had a modest correlation with PCWP ( r =0.44, P <0.0001), and accuracy was 73%; NT‐proBNP correlated weakly with PCWP ( r =0.24, P <0.001), and accuracy was 57%. Conclusions: The 2016 ASE/EACVI algorithm for the assessment of diastolic function has a limited diagnostic accuracy in patients evaluated for unexplained dyspnea and/or pulmonary hypertension, and especially sensitivity to detect diastolic dysfunction was low.

1 February 2022 in Circulation: Heart Failure
Verified
Journal Article
Open access
PDF file
JWJessie van Wezenbeek
Jessie van Wezenbeek
AKAzar Kianzad
Azar Kianzad
ABArno van de Bovenkamp
Arno van de Bovenkamp
JWJeroen Wessels
Jeroen Wessels
SMSophia Anastasia Mouratoglou
Sophia Anastasia Mouratoglou
FMFrances S. De Man
Frances S. De Man
Background: Heart failure with preserved ejection fraction (HFpEF) is a prevalent disorder for which no effective treatment yet exists. Pulmonary hypertension (PH) and right atrial (RA) and ventricular (RV) dysfunction are frequently observed. The question remains whether the PH with the associated RV/RA dysfunction in HFpEF are markers of disease severity. Methods: To obtain insight in the relative importance of pressure-overload and left-to-right interaction, we compared RA and RV function in 3 groups: 1. HFpEF (n=13); 2. HFpEF-PH (n=33), and; 3. pulmonary arterial hypertension (PAH) matched to pulmonary artery pressures of HFpEF-PH (PH limited to mPAP ≥30 and ≤50 mmHg) (n=47). Patients underwent right heart catheterization and cardiac magnetic resonance imaging. Results: The right ventricle in HFpEF-PH was less dilated and hypertrophied than in PAH. In addition, RV ejection fraction was more preserved (HFpEF-PH: 52±11 versus PAH: 36±12%). RV filling patterns differed: vena cava backflow during RA contraction was observed in PAH only. In HFpEF-PH, RA pressure was elevated throughout the cardiac cycle (HFpEF-PH: 10 [8–14] versus PAH: 7 [5–10] mm Hg), while RA volume was smaller, reflecting excessive RA stiffness (HFpEF-PH: 0.14 [0.10–0.17] versus PAH: 0.08 [0.06–0.11] mm Hg/mL). RA stiffness was associated with an increased eccentricity index (HFpEF-PH: 1.3±0.2 versus PAH: 1.2±0.1) and interatrial pressure gradient (9 [5 to 12] versus 2 [−2 to 5] mm Hg). Conclusions: RV/RA function was less compromised in HFpEF-PH than in PAH, despite similar pressure-overload. Increased RA pressure and stiffness in HFpEF-PH were explained by left atrial/RA-interaction. Therefore, our results indicate that increased RA pressure is not a sign of overt RV failure but rather a reflection of HFpEF-severity.

19 March 2020 in New England Journal of Medicine
Verified
Journal Article
Closed access
ABArno A van de Bovenkamp
Arno A van de Bovenkamp
ARAlbert C van Rossum
Albert C van Rossum
MHM Louis Handoko
M Louis Handoko
To the Editor: Solomon et al. (Oct. 24 issue)1 report on the results of the PARAGON-HF (Prospective Comparison of ARNI [angiotensin receptor–neprilysin inhibitor] with ARB [angiotensin-receptor blockers] Global Outcomes in HF with Preserved Ejection Fraction) trial, which showed a lack of effect of sacubitril–valsartan in patients who had heart failure with preserved ejection fraction. The contrast of these results with those showing a benefit of sacubitril–valsartan in patients who have heart failure with reduced ejection fraction2 has mainly been attributed to the heterogeneity of the population of patients who have heart failure with preserved ejection fraction.3 We would like to . . .

1 November 2022 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Open access
PDF file
ADAhmet Demirkiran
Ahmet Demirkiran
LRLourens Robbers
Lourens Robbers
NHNina W. van der Hoeven
Nina W. van der Hoeven
HEHenk Everaars
Henk Everaars
LHLuuk H.G.A. Hopman
Luuk H.G.A. Hopman
RNRobin Nijveldt
Robin Nijveldt
Background: The invasive microvascular function indices, coronary flow reserve (CFR) and the index of microcirculatory resistance (IMR), exhibit a dynamic pattern after ST-segment–elevation myocardial infarction. The effects of microvascular injury on the evolution of the microvascular function and the prognostic significance of the evolution of microvascular function are unknown. We investigated the relationship between the temporal changes of CFR and IMR, and cardiovascular magnetic resonance-derived microvascular injury characteristics in reperfused ST-segment–elevation myocardial infarction patients, and their association with 1-month left ventricular ejection fraction and infarct size (IS). Methods: In 109 ST-segment–elevation myocardial infarction patients who underwent angiography for primary percutaneous coronary intervention (PPCI) and at 1-month follow-up, invasive assessment of CFR and IMR were performed in the culprit artery during both procedures. Cardiovascular magnetic resonance was performed 2 to 7 days after PPCI and at 1 month and provided assessment of left ventricular ejection fraction, IS, microvascular obstruction, and intramyocardial hemorrhage. Results: CFR and IMR significantly changed over 1 month (both, P <0.001). The absolute IMR change over 1 month (ΔIMR) showed association with both microvascular obstruction and intramyocardial hemorrhage presence (both, P =0.01). ΔIMR differed between patients with/without microvascular obstruction ( P =0.02) and with/without intramyocardial hemorrhage ( P =0.04) but not ΔCFR for both. ΔIMR demonstrated association with both left ventricular ejection fraction and IS at 1 month ( P 50% and extensive IS (the highest quartile). Conclusions: In reperfused ST-segment–elevation myocardial infarction patients, CFR and IMR significantly improved 1 month after PPCI; the temporal change in IMR is closely related to the presence/absence of microvascular damage and IS. ΔIMR exhibits a stronger association for 1-month functional outcome than post-PPCI CFR, IMR, or ΔCFR.

1 March 2025 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Open access
ABArno A. van de Bovenkamp
Arno A. van de Bovenkamp
SNSoufiane Nassiri
Soufiane Nassiri
ABAdrianus J. Bakermans
Adrianus J. Bakermans
GBGeorge L. Burchell
George L. Burchell
FMFrances S. De Man
Frances S. De Man
MHM. Louis Handoko
M. Louis Handoko
In contrast to acute responses, long-term treatment exerted little long-term afterload reduction and stroke volume augmentation in both HFpEF and HFrEF. Reverse remodeling was clearly present in HFrEF but was hardly observed in HFpEF. These results suggest a lesser importance of any increase in stroke volume (due afterload reduction) compared with reverse remodeling in the long-term effects of heart failure medication.